Catechol

Catechol

SCHEMBL2804789

O=C1CNC(=O)N1.Oc1ccccc1O.[SiH4]

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.40
MAPT P10636 3/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
ALDH1A1 P00352 2/20 0.40
POLB P06746 2/20 0.40
RAB9A P51151 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
NPC1 O15118 1/20 0.40
CA12 O43570 1/20 0.40
GMNN O75496 1/20 0.40
EGFR P00533 1/20 0.40
CA2 P00918 1/20 0.40
LMNA P02545 1/20 0.40
FYN P06241 1/20 0.40
CA3 P07451 1/20 0.40
CYP3A4 P08684 1/20 0.40
MMP9 P14780 1/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
NFKB1 P19838 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydantoin SCHEMBL27362965 0.84 TDP1 (0.44) KDM4EMAPTL3MBTL1ALDH1A1TDP1
2-Phenylphenol SCHEMBL8682334 0.83 ALDH1A1 (0.55) L3MBTL1ALDH1A1RAB9AHPGDALOX15
Hydantoin SCHEMBL27574136 0.80 CRBN (0.46) MAPTL3MBTL1ALDH1A1TDP1CA12
Hydantoin SCHEMBL9422302 0.80
Hydantoin SCHEMBL5011714 0.80
Biphenyl SCHEMBL1712625 0.79 TYRO3 (0.42) KDM4EALDH1A1LMNAMMP9HPGD
Hydantoin SCHEMBL27916388 0.79 TRPA1 (0.55) KDM4EMAPTL3MBTL1ALDH1A1POLB
Biphenyl SCHEMBL9013643 0.78 TYRO3 (0.41) KDM4EALDH1A1LMNAMMP9HPGD
Hydantoin SCHEMBL27690 0.78
Hydantoin SCHEMBL27705088 0.78 CRBN (0.52) MAPTL3MBTL1ALDH1A1TDP1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1924734-B1 METHOD FOR ATTACHMENT OF SILICON-CONTAINING COMPOUNDS TO A SURFACE AND FOR THE SYNTHESIS OF HYPERVALENT SILICON-COMPOUNDS ALEXIUM INC (US) 2017-01-04 EP disclosed
US-20120128930-A1 Method for Attachment of Silicon-Containing Compounds to a Surface and for Synthesis of Hypervalent Silicon-Compounds UNITED STATES AIR FORCE 2012-05-24 US disclosed
US-20100239784-A1 Method for attachment of silicon-containing compounds to a surface and for synthesis of hypervalent silicon-compounds ALEXIUM, INC. 2010-09-23 US disclosed
EP-1924734-A1 METHOD FOR ATTACHMENT OF SILICON-CONTAINING COMPOUNDS TO A SURFACE AND FOR THE SYNTHESIS OF HYPERVALENT SILICON-COMPOUNDS Alexium Limited (CY) 2008-05-28 EP disclosed
WO-2007031775-A1 METHOD FOR ATTACHMENT OF SILICON-CONTAINING COMPOUNDS TO A SURFACE AND FOR THE SYNTHESIS OF HYPERVALENT SILICON-COMPOUNDS ALEXIUM LIMITED (CY) 2007-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120128930-A1 Method for Attachment of Silicon-Containing Compounds to a Surface and for Synthesis of Hypervalent Silicon-Compounds VCL, PDS5B, PDS5A KDM4E 2824/4885MAPT 1502/4885L3MBTL1 2712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.